What are the symptoms and treatment of diabetes type 1?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Type 1 Diabetes

The classic symptoms of type 1 diabetes include polyuria (excessive urination), polydipsia (excessive thirst), weight loss, polyphagia (increased hunger), fatigue, and blurred vision, typically occurring for several days to a few weeks prior to diagnosis. 1

Clinical Presentation

Type 1 diabetes symptoms typically develop rapidly and can be categorized as follows:

Common Initial Symptoms

  • Polyuria - Excessive urination due to osmotic diuresis from hyperglycemia
  • Polydipsia - Extreme thirst resulting from fluid loss and dehydration
  • Unexplained weight loss - Despite increased appetite
  • Polyphagia - Increased hunger
  • Fatigue - Due to inability to use glucose for energy
  • Blurred vision - From lens swelling caused by osmotic effects of chronic hyperglycemia 1

Advanced or Severe Symptoms

  • Diabetic ketoacidosis (DKA) symptoms:
    • Nausea and vomiting
    • Abdominal pain
    • Fruity breath odor (from ketones)
    • Rapid breathing
    • Confusion or altered mental status
    • Potential progression to loss of consciousness, seizure, or coma 1

Diagnostic Criteria

Type 1 diabetes can be diagnosed through the following criteria:

  • Random plasma glucose ≥200 mg/dL (11.1 mmol/L) with classic symptoms of hyperglycemia 1
  • Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) after no caloric intake for at least 8 hours
  • 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during oral glucose tolerance test
  • HbA1c ≥6.5% (48 mmol/mol) 1

Stages of Type 1 Diabetes Development

Type 1 diabetes develops in three distinct stages:

  1. Stage 1: Presymptomatic with β-cell autoimmunity (≥2 islet autoantibodies) and normoglycemia
  2. Stage 2: Presymptomatic with β-cell autoimmunity and dysglycemia
  3. Stage 3: Symptomatic disease with insulin deficiency 1

Treatment Approach

The cornerstone of type 1 diabetes treatment is insulin replacement therapy:

Insulin Therapy

  • Multiple daily injections (MDI) - 3-4 injections per day of basal and prandial insulin
  • Continuous subcutaneous insulin infusion (CSII) via insulin pump 1
  • Most patients should be educated to match prandial insulin doses to carbohydrate intake, pre-meal blood glucose levels, and anticipated activity 1

Insulin Types and Administration

  • Basal insulin: Long-acting insulin analogs (e.g., insulin glargine) typically administered once daily at bedtime 2
  • Bolus insulin: Rapid-acting insulin administered before meals
  • Typical distribution: 50% basal insulin and 50% bolus insulin 3

Monitoring

  • Self-monitoring of blood glucose (SMBG)
  • Continuous glucose monitoring (CGM) - Particularly beneficial for patients with frequent hypoglycemia or hypoglycemia unawareness 4

Hypoglycemia Management

  • For mild to moderate hypoglycemia (blood glucose <70 mg/dL): 15-20g of fast-acting carbohydrates, preferably glucose
  • For severe hypoglycemia: Glucagon administration by caregivers or family members 4
  • Patients should be advised to carry fast-acting carbohydrates at all times 4

Complications to Monitor

Untreated or poorly controlled type 1 diabetes can lead to:

Acute Complications

  • Diabetic ketoacidosis (DKA) - Life-threatening condition requiring immediate medical attention
  • Severe hypoglycemia - Can progress to loss of consciousness, seizure, coma, or death 1, 5

Chronic Complications

  • Microvascular: Retinopathy, nephropathy, neuropathy
  • Macrovascular: Coronary artery disease, peripheral vascular disease
  • Regular screening for these complications is essential 5

Important Considerations

  • Early diagnosis and treatment are critical - The metabolic state of untreated children with type 1 diabetes can deteriorate rapidly 1
  • Delays in diagnosis and insulin therapy must be avoided to prevent progression to DKA 1
  • Hypoglycemia awareness should be assessed regularly, as repeated episodes can lead to hypoglycemia unawareness 4
  • Adjunctive therapies such as pramlintide may be considered in some patients but are not first-line treatments 1, 3

Type 1 diabetes requires lifelong insulin therapy, and proper education on insulin administration, carbohydrate counting, and hypoglycemia management is essential for optimal outcomes and quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diabetes: Type 1 Diabetes.

FP essentials, 2021

Guideline

Hypoglycemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute and Chronic Adverse Outcomes of Type 1 Diabetes.

Endocrinology and metabolism clinics of North America, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.